v3.25.2
Segment Reporting (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
segment
Jun. 30, 2024
USD ($)
Segment Reporting Information [Line Items]            
Number of reportable segments | segment         1  
Operating expenses            
Total operating expenses $ 49,855   $ 32,904   $ 98,076 $ 62,103
Operating loss (49,855)   (32,904)   (98,076) (62,103)
Other income, net 664   2,406   1,866 4,458
Net loss (49,191) $ (47,019) (30,498) $ (27,147) (96,210) (57,645)
Reportable Segment            
Operating expenses            
Compensation and benefits 16,032   13,469   32,338 27,929
Clinical trial and manufacturing 18,707   4,483   29,680 7,838
Facilities and IT 6,045   9,594   17,793 16,562
Other research and development 2,815   945   4,958 1,726
Other segment 6,256   4,413   13,307 8,048
Total operating expenses 49,855   32,904   98,076 62,103
Operating loss (49,855)   (32,904)   (98,076) (62,103)
Other income, net 664   2,406   1,866 4,458
Net loss $ (49,191)   $ (30,498)   $ (96,210) $ (57,645)